Jaundice
Bridging Pathophysiology and Herbal Medicine in a Holistic Framework
DOI:
https://doi.org/10.64261/yyk57v74Keywords:
Jaundice, bilirubin, hepatoprotection, herbal medicine, integrative therapy, phytotherapy, holistic health.Abstract
Jaundice, which results in yellowish skin, sclerae, and mucous membranes, is a typical clinical sign of elevated blood bilirubin levels. It is caused by several disease processes affecting the liver, bile ducts, or red blood cells. This study reviews the causes of jaundice, diagnostic techniques, and available treatments, with an emphasis on using herbal medicine in addition to conventional therapy. The combination of traditional and modern medicine offers a holistic framework that enhances liver function, encourages cleansing, and reduces issues. Evidence- based herbal remedies with noteworthy hepatoprotective properties include Silybum marianum, Curcuma longa, Phyllanthus niruri, and Picrorhiza kurroa. This review promotes integrative and patient-centered care in pharmacy practice while highlighting the mechanisms, advantages, and drawbacks of herbal therapies.
References
1. Aggarwal, B. B., &Harikumar, K. B. (2009). Curcumin is an anti-inflammatory that may be used to treat neoplastic, neurological, cardiovascular, pulmonary, metabolic, and autoimmune illnesses. Biochemistry & Cell Biology International Journal, 41(1), 40–59. DOI: https://doi.org/10.1016/j.biocel.2008.06.010
2. Chander, R., & Kapoor. (1990). Hepato protective effects of Picrorhiza kurroa
Against liver damage caused by carbon tetrachloride. PlantaMedica,56(6), 653–657.
3. Crawford, J.M. (2019). The liver and biliary tract. In Robbins and Cotran Pathologic Basis of Disease (10th ed.). Elsevier.
4. Gowda, S., Desai, P. B., Hull, V. V., & Math, A. A. (2020). A review on laboratory liver function tests. Pan African Medical Journal, 37(1), 1–8.
5. Kaur, Karur. (2020). Phyto therapeutic potential of dandelion: A review. International Journal of Herbal Medicine,8(3), 45–51.
6. Kumar, V., & Abbas, A. K. (2021). Robbins Basic Pathology(11thed.). Elsevier. DOI: https://doi.org/10.33029/9704-6467-0-KRB-2022-1-1036
7. Lee, W. M. (2018). Acetaminophen (APAP) hepatotoxicity—Isn't it time for APAP to go away Journal of Hepatology, 67(6), 1324–1331. DOI: https://doi.org/10.1016/j.jhep.2017.07.005
8. Loguercio, C., & Festa, D. (2011). Silybin and the liver: From basic research to clinical practice. World Journal of Gastroenterology, 17(18), 2288–2301. DOI: https://doi.org/10.3748/wjg.v17.i18.2288
9. Mishra, R., & Sharma, N. (2021). Role of herbal hepatoprotective agents in liver disorders: A review. Pharmacognosy Reviews, 15(29), 30–41.
10. Sherlock, S., & Dooley, J. (2020). Diseases of the Liver and Biliary System (13th ed.). Wiley-Blackwell.
11. Thyagarajan, S. P., Blumberg, B. S., Venkateswaran, P. S., Subramanian, S., and Thirunal Sundari, T. (2002). Phyllanthus amaro’s impact on long-term hepatitis B virus carriers. The Lancet, 2(8614), 764-766.
12. World Health Organization. (2021). WHO monographs on selected medicinal plants (Vol.1–5). WHO Press.
13. Upadhyay, U. C., Ahmad, S., Singh, K., Ahmad, S. N., & Shahabuddin. (1999). Preliminary hepatoprotective activity of carbohydrate fraction from Picrorhiza kurroa. Indian Journal of Pharmaceutical Sciences, 61(4), 283–286.
14. Yadav, M., Singh, G., & Gupta, A. (2021). Herbal hepatoprotective agents: A review on mechanistic insights and clinical evidence. Journal of Herbal Medicine, 28, 100483. https://doi.org/10.1016/j.hermed.2021.100483 DOI: https://doi.org/10.1016/j.hermed.2021.100483
15. Nagarajan, S. (2022). An overview of chemicals from medicinal plants that may be hepatoprotective. Pharmacophore, 13(4), 8–22. https://doi.org/10.51847/9jMktTwwjl. DOI: https://doi.org/10.51847/9jMktTwwjl
16. Liu, S., Liu, X., & Qiao, J. (2017). Herbal hepatoprotective drugs with least nephrotoxic side effects. Journal of Nephro pharmacology, 6(2), 38–48. https://doi.org/10.15171/npj.2017.03 DOI: https://doi.org/10.15171/npj.2017.03
17. Koleva, I. I., van Beek, T. A., Linssen, J. P., Evstatieva, L. N., and de Groot, A. (2002). An analysis of three testing techniques for screening plant extracts for antioxidant activity. 13(1), 8–17; Phytochemical Analysis. DOI: https://doi.org/10.1002/pca.611
18. Dong, H., & Wu, Y. (2018). Herbal- and dietary-supplement-induced liver injury: Epidemiology and mechanisms. Clinics in Liver Disease, 22(4), 1–17.
19. Zheng, Q., Wang, X., & Li, Z. (2023). Promising hepatoprotective agents from natural sources: Current trends and novel insights. European Journal of Gastroenterology & Hepatology, 35(3), 167–175.
20. Zhang, Y., Li, S., & Li, J. (2021). Mechanisms of herb-induced liver injury (HILI): A comprehensive review. Frontiers in Pharmacology, 12, 668396.
21. Zhao, H., Xu, G., & Wang, Y. (2020). Natural products as hepatoprotective agents – A comprehensive review. Plants, 9(14), 1985.
22. Patel, V., & Patel, J. (2022). Hepatoprotective potential of selected medicinal herbs—A review. Phytochemistry Reviews, 21(5), 1303–1323.
23. Singh, N., & Bhatia, A. (2020). Evaluation of hepatoprotective activity of Andrographis paniculata extract in rats. Indian Journal of Experimental Biology, 58(2), 102–110.
24. Niu, Y., & Dong, Q. (2017). Silymarin in liver diseases: Molecular mechanisms and therapeutic potential. Journal of Hepatology Research, 67(8), 135–148.
25. Basu, S., & Maier, K. (2018). Oxidative stress, inflammation, and liver injury: A review. ClinicalLiverDisease,11(5),164–170.
26. Gupta, S., & Choudhary, R. (2021). Role of antioxidants in hepatic diseases. World Journal of Hepatology, 13(8), 1004–1015.
27. Chen, H., Zhang, Y., & Sun, B. (2020). Effects of Glycyrrhiza glabra on hepatoprotection and anti-inflammatory activity. Journal of Ethnopharmacology, 259, 112933. DOI: https://doi.org/10.1016/j.jep.2020.112948
28. Wang, J., & Zhao, J. (2019). Mechanistic studies on curcumin-mediated hepatoprotection. Liver Research, 3(4), 186–195. DOI: https://doi.org/10.1016/j.livres.2018.10.001
29. Alam, M. N., Bristi, N. J., & Rafiq Uzza man, M. (2013). Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharmaceutical Journal, 21(2), 143– 152. DOI: https://doi.org/10.1016/j.jsps.2012.05.002
30. Pannu, N., & Singh, M. (2020). Role of Phyllanthus species in the treatment of liver disorders. Asian Journal of Pharmaceutical and Clinical Research, 13(5), 12–18.
31. Teschke, R., & Eickhoff, A. (2016). Herbal hepatotoxicity in traditional and modern medicine: Clinical and regulatory challenges. Frontiers in Pharmacology, 7, 451. DOI: https://doi.org/10.3389/fphar.2015.00072
32. Kalra, A., & Kumar, V. (2019). Hepatotoxicity associated with herbal and dietary supplements: A systematic review. Journal of Clinical and Experimental Hepatology, 9(4), 484–495.
33. Shah, S., & Patel. (2021). Pharmacogenetic study and hepato protective role of Boer haavia diffusa. Journal of Pharmacognosy and Phytochemistry,10(2), 90–96.
34. Tripathi, R., & Verma, S. (2019). Herbal hepatoprotective remedies: Mechanisms and clinical evidence. Journal of Pharmacology & Phytochemistry, 8(6), 2263–2270.
35. Banerjee, T., & Prasad, S. (2021). The role of oxidative stress in liver disorders and its management using natural antioxidants. Antioxidants, 10(3), 400–415.
36. Singh, A., & Gupta, S. (2020). Integration of phytotherapy and modern pharmacology in hepatoprotective drug development. Indian Journal of Natural Products and Resources, 11(3), 150–162.
37. Pandey, R., & Sharma. (2018). Phyto chemicals in hepato protection: Asian Pacific Journal of Tropical Medicine,11(8), 470–479.
38. Sarkar, A., & Mitra, S. (2021). Detoxifying herbs in Ayurveda for jaundice: A pharmacological overview. Journal of Ayurveda and Integrative Medicine, 12(2), 250– 258.
39. Raj, V & Kumar, A. (2019). Nutraceutical and herbal interventions in hepatic disorders. Frontiers in Nutrition, 6,142.
40. Das, K., & Roy, S. (2023). Herbal formulations in jaundice: A mechanistic and clinical evaluation. Journal of Herbal Pharmacotherapy, 23(1), 55–72. https://doi.org/10.1080/15228959.2023.1167
Downloads
Published
Issue
Section
Categories
- Clinical and Biomedical Sciences
- Ethics, Equity, and Social Justice in Health
- Health Systems and Policy
- Indigenous Knowledge and Culture
- Mental Health and Psychological Wellbeing
- Psychosocial and Behavioral Sciences
- Public Health
- Trauma, Conflict, and Humanitarian Health
- Pharmaceutical and Therapeutic Sciences
License
Copyright (c) 2026 Pan-African Journal of Health and Psychological Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Pan-African Journal of Health and Psychological Sciences (PAJHPS) are open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Under this license:
-
Authors retain copyright and grant the journal the right of first publication.
-
The work may be shared, copied, redistributed, and adapted for any purpose, even commercially.
-
Appropriate credit must be given to the original author(s) and the journal, along with a link to the license.
-
Users must indicate if changes were made.
-
There are no restrictions on reuse, provided the original work is properly cited.
Citation:
Authors and users must cite the original work in the following manner:
Author(s). (Year). Title of the article. Pan-African Journal of Health and Psychological Sciences, Volume(Issue), page range. https://doi.org/xx.xxxx/pajhps.vXnY.xxx
Copyright Statement:
Authors grant PAJHPS a non-exclusive license to publish the work and identify itself as the original publisher. Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version (e.g., post it to a repository or publish it in a book), with acknowledgment of its initial publication in this journal.